empty
 
 
it
Search
Supporto
Apertura rapida di un conto
Piattaforma di trading
Ricaricare / Prelevare
Search
Per principianti Per trader Per partner Fai una pausa Chi siamo
it
Per i trader
Grafici
#DVAX

#DVAX (Dynavax Technologies Corporation). Tasso di cambio e grafici online.

#DHR Tornare a tutti gli strumenti #DXCM

Convertitore di valute

Dynavax Technologies Corporation
10.89 USD
09 Dec 2025 22:59
Variazione del prezzo (% chg)
$-0.02
(-0.18%)
Chiusura
Chiusura

Prezzo di chiusura, giorno precedente.
$10.96
Apertura
Apertura

Prezzo di apertura.
$10.93
Prezzo massimo
Prezzo massimo

Prezzo massimo nell'ultimo giorno di negoziazioni.
$11.12
Prezzo minimo
Prezzo minimo

Prezzo minimo nell'ultimo giorno di negoziazioni.
$10.85
Massimo 52 settimane.
Massimo 52 settimane.

Prezzo massimo nelle ultime 52 settimane.
$11.28
Mnimo 52 settimane.
Mnimo 52 settimane.

Prezzo minimo nelle ultime 52 settiimane.
$10.62
Scaricare l'archivio
Acquista
10.89
Vendi
10.89
Apri il grafico a schermo intero
Acquista
10.89
Vendi
10.89
Scaricare l'archivio
Apri il grafico a schermo intero

Dynavax Technologies Corporation. About company

Dynavax Technologies Corporation is a biopharmaceutical company whose core business is the development and production of vaccines.

The company’s main product is a hepatitis B drug. The company also produces vaccines against coronavirus, influenza, plague, and other infectious diseases.

In addition, the company is mainly focused on the production of adjuvants. These substances help vaccines to be better absorbed by the body.

Currently, Dynavax has a market capitalization of $1.37 billion. Last year, the company posted revenues of $438.24 million and a net income of $76.71 million.

Dynavax Technologies Corporation’s shares and what affects their price

Dynavax shares have been trading on the NASDAQ exchange under the DVAX ticker since 2004. The initial price per share stood at $7.50.

Currently, the company’s shares are trading between $10 and $12. During the year, the share price was hovering between $7 and $22. At the same time, the company does not pay dividends to its shareholders.

What to pay attention to when trading the company’s shares:

  • Long-term growth prospects are driven by a large number of innovative developments;
  • The target price for the stock is several times higher than the current one, ranging between $45.5 and $48, according to forecasts;
  • Adjuvant technology is an advantage for the company since these additional substances significantly enhance the effect of the vaccines.

In questo momento non potete parlare al telefono?
Ponete la vostra domanda nella chat.